Dato' Dr. Mohd Nazlee bin Kamal, Ph.D. is Deputy Managing Director, Executive Director of the Company. From 1986 - B. Sc. Chemical Engineering, Oregon State University, USA 2. 1989 - M. App. Sc. Biotechnology, University of New South Wales, Australia 3. 1996 - PhD. Chemical Engineering, University of Queensland, Australia 4. Member of International Society for Pharmaceutical Engineering 5. Member of Institution of Chemical Engineers Malaysia 6. Member of Microbiology Society.
From 2015-2016 Member of National Blue Ocean Strategy Committee 2011-2016 Chairman/Director, Malaysian Bio-XCell Sdn Bhd 2014-2016 Director, Johor Biotechnology & Biodiversity Corporation 2014-2016 Director, Malaysian Global Innovation and Creativity Centre (MAGIC) 2012-Present Director, National Institutes of Biotechnology Malaysia (NIBM) 2012-2016 Director, Melaka Biotechnology Corporation 2011-2016 Director, Malaysian Biotechnology Corporation Sdn Bhd 2011-2016 Director, BiotechCorp Investment Holding Sdn Bhd 2011-2016 Director, BiotechCorp Technology Management Sdn Bhd 2011-2015 Director, Malaysia Forestry Research and Development Board (MFRDB) 2012-2016 Taskforce Member, 1Malaysia Biomass Alternative Strategy (1MBAS) 2014-2016 Council Member, Malaysian Standards and Accreditation Council (MSDAM) 2011-2016 Council Member, National Innovation Council (NIC) 2011-2016 Ex-officio, Global Science and Innovation Advisory Council (GSIAC) 2015-Present Member, Advisory Council for German-Malaysian Society e.V (DtMG) 2011-2016 Member, Advisory Panel for NCIAs Plant Science and Tissue Culture Node (PSTCN) 2014-2016 Member, Advisory Panel for School of Biological Sciences, Universiti Sains Malaysia 2011-2016 Steering Committee, Agriculture NKEA 2002-2011 Director, Inno Bio Ventures Sdn Bhd 2002-2011 Director, Inno Biologics Sdn Bhd
haha no laa mr president.. paktua is gilaa oldman.. master conman.. autasing rank no 1 penipu besar.. otak belit bla bla but.. all dia orang cakaplaa hehehe
SOLUTN 1.330 +0.21 (+18.7%) Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020 SOLUTION GROUP BERHAD
Financial Year End 31 Dec 2020 Quarter 3 Qtr Quarterly report for the financial period ended 30 Sep 2020 The figures have not been audited Attachments SOLUTN-3rd Qtrly Report 2020.pdf 61.3 kB Default CurrencyOther Currency Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2020
INDIVIDUAL PERIOD CUMULATIVE PERIOD CURRENT YEAR QUARTER PRECEDING YEAR CORRESPONDING QUARTER CURRENT YEAR TO DATE PRECEDING YEAR CORRESPONDING PERIOD 30 Sep 2020 30 Sep 2019 30 Sep 2020 30 Sep 2019 $$'000 $$'000 $$'000 $$'000 1 Revenue 5,288 4,873 12,209 13,670 2 Profit/(loss) before tax 577 235 322 -98 3 Profit/(loss) for the period 577 309 322 -24 4 Profit/(loss) attributable to ordinary equity holders of the parent 416 262 83 -156 5 Basic earnings/(loss) per share (Subunit) 0.14 0.09 0.03 -0.05 6 Proposed/Declared dividend per share (Subunit) 0.00 0.00 0.00 0.00
AS AT END OF CURRENT QUARTER AS AT PRECEDING FINANCIAL YEAR END 7 Net assets per share attributable to ordinary equity holders of the parent ($$) 0.1244 0.1228
Wah.its reach TP.But feel its can reach higher.Vaccine not price at rm 10-20 but I hear its price at rm 80-rm 150 per doses.
Solution at 75 cents
Posted by Michael Kwok > Nov 5, 2020 8:48 PM | Report Abuse X
Personally after argument broke out,I intended to buy Solution afternoon section with rm 10k (price 75 cents).After Seing some familiar pattern my arrogant gone.KYY say never be arrogant.I put a TP of rm 1.20-rm 1.40.Being able to supply for ASEAN countries look good prospect.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
HuatEveryday
475 posts
Posted by HuatEveryday > 2020-11-26 17:15 | Report Abuse
Took profit... have a good ride here! Will visit again when the time is right! Good luck guys!